Early thromboelastometry variables predict maximum clot firmness in children undergoing cardiac and non-cardiac

A Perez-Ferrer1, J Vicente-Sanchez1, M D Carceles-Baron2

  • 1Department of Anaesthesiology, La Paz University Hospital, Madrid, Spain.

Insights

Early clot amplitudes measured on rotational thromboelastometry (ROTEM®) can predict maximum clot firmness (MCF) in pediatric patients. This finding supports using early ROTEM® variables for assessing clot strength in children undergoing surgery.

Area of Science:

  • Pediatric Anesthesiology
  • Hemostasis and Thrombosis Research
  • Point-of-Care Testing

Background:

  • Rotational thromboelastometry (ROTEM®) is a viscoelastic assay used to assess hemostasis.
  • Early clot amplitudes in ROTEM® have been shown to predict maximum clot firmness (MCF) in adults.
  • The predictive value of early ROTEM® variables for MCF in pediatric surgical patients was previously unconfirmed.

Purpose of the Study:

  • To confirm the correlation between early clot amplitudes and MCF in children.
  • To evaluate the predictive accuracy of early ROTEM® variables across various test assays in pediatric patients.
  • To establish the utility of early ROTEM® measurements in pediatric cardiac and non-cardiac surgery.

Main Methods:

  • Retrospective analysis of 4762 ROTEM® tests (EXTEM, INTEM, FIBTEM, APTEM, HEPTEM) from pediatric patients.
  • Correlation analysis (Spearman's coefficient) between clot amplitudes at 5, 10, and 15 minutes and MCF.
  • Receiver operating characteristics (ROC) analysis to assess predictive performance.

Main Results:

  • Strong correlations were observed between early clot amplitudes (A5, A10, A15) and MCF for EXTEM, INTEM, and FIBTEM tests (r values ranging from 0.91 to 0.97, P<0.001).
  • Similar strong correlations were found for APTEM and HEPTEM tests.
  • ROC analysis confirmed that early clot amplitudes reliably predicted MCF across all ROTEM® assays.

Conclusions:

  • Early clot amplitudes measured as early as 5, 10, or 15 minutes after clotting time accurately predict MCF in pediatric patients.
  • These findings validate the use of early ROTEM® measurements for assessing hemostasis in children undergoing surgery.
  • The study supports the integration of early ROTEM® variable assessment into pediatric perioperative hemostasis management.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
465
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
434